Cost-effectiveness of Freestyle Libre Systems for People with Type 2 Diabetes Mellitus on Basal Insulin Therapy in the Netherlands: An Economic Evaluation from a Societal Perspective Within a Publicly Funded Healthcare System
From a Dutch publicly funded healthcare system perspective, FSL can be considered to be cost-effective compared with SMBG for people living with T2DM on basal insulin therapy.
Authors
- Peter R. van Dijk (ORCID: https://orcid.org/0000-0002-9702-6551)
- Jack Timmons (ORCID: https://orcid.org/0009-0001-5577-4017)
- Julia Bakker
- Christopher Chesters (ORCID: https://orcid.org/0009-0009-2209-9754)
- Kirk Szafranski
- Fleur Levrat-Guillen
Institutions
- Abbott (United Kingdom) (GB)
- Diabetes Care Center (US)
- Isala (NL)
- EVERSANA (Canada) (CA)
Publication Details
- Journal
- Diabetes Therapy
- Published
- 2025-11-28
- DOI
- https://doi.org/10.1007/s13300-025-01821-9
- Primary Topic
- Diabetes Management and Education
- Type
- article
- Field-Weighted Citation Impact
- 0.00